Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Corcept Therapeutics (CORT)
Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,755,329
  • Shares Outstanding, K 103,080
  • Annual Sales, $ 401,860 K
  • Annual Income, $ 101,420 K
  • 60-Month Beta 0.35
  • Price/Sales 6.94
  • Price/Cash Flow 27.32
  • Price/Book 5.91
Trade CORT with:

Options Overview Details

View History
  • Implied Volatility 75.96% ( -3.99%)
  • Historical Volatility 37.57%
  • IV Percentile 96%
  • IV Rank 82.05%
  • IV High 90.85% on 10/02/23
  • IV Low 7.91% on 06/05/23
  • Put/Call Vol Ratio 4.40
  • Today's Volume 54
  • Volume Avg (30-Day) 235
  • Put/Call OI Ratio 1.06
  • Today's Open Interest 13,773
  • Open Int (30-Day) 14,433

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.25
  • Number of Estimates 5
  • High Estimate 0.27
  • Low Estimate 0.21
  • Prior Year 0.14
  • Growth Rate Est. (year over year) +78.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.44 +9.59%
on 11/13/23
27.13 -1.27%
on 12/06/23
+1.02 (+3.98%)
since 11/08/23
3-Month
24.44 +9.59%
on 11/13/23
34.28 -21.85%
on 09/14/23
-6.15 (-18.69%)
since 09/08/23
52-Week
17.86 +49.97%
on 03/01/23
34.28 -21.85%
on 09/14/23
+3.77 (+16.41%)
since 12/08/22

Most Recent Stories

More News
Vertex Pharmaceuticals (VRTX) Post-Earnings Analysis: Is It Time to Buy the Stock?

After a solid third-quarter earnings report, does Vertex Pharmaceuticals (VRTX) deserve a place in your portfolio? Let’s look at its financial metrics to gauge its prospects… Vertex Pharmaceuticals...

CORT : 26.66 (-0.26%)
GILD : 78.46 (+0.53%)
OTSKY : 18.6900 (-5.27%)
VRTX : 350.48 (-0.98%)
Gilead Sciences (GILD) Earnings Forecast and Gameplan

Gilead Sciences (GILD) boasts an impressive product portfolio and has surpassed the consensus estimate on the topline in each of the trailing four quarters. With the company gearing up to post its third...

ALXN : 182.50 (+1.70%)
CORT : 26.66 (-0.26%)
GILD : 78.46 (+0.53%)
OTSKY : 18.6900 (-5.27%)
Corcept: Q3 Earnings Snapshot

Corcept: Q3 Earnings Snapshot

CORT : 26.66 (-0.26%)
3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records...

CORT : 26.66 (-0.26%)
REGN : 845.08 (-0.48%)
Unlocking Biotech's Potential With 3 Stocks to Buy

The biotech industry’s growth is propelled by strong demand for medical support and interventions, favorable government initiatives, and rapid adoption of emerging technologies. Given the industry’s...

CORT : 26.66 (-0.26%)
SGIOY : 12.2600 (+1.49%)
UTHR : 241.08 (-0.41%)
Which Stock Do Investors Consider a Heathier Investment: Bionano Genomics (BNGO) vs. Corcept Therapeutics (CORT)

The biotech industry is poised for long-term growth supported by government initiatives and the rising prevalence of chronic illnesses. While biotech stocks Bionano Genomics (BNGO) and Corcept Therapeutics...

BNGO : 1.5250 (+0.33%)
CORT : 26.66 (-0.26%)
Corcept: Q2 Earnings Snapshot

Corcept: Q2 Earnings Snapshot

CORT : 26.66 (-0.26%)
Time to Capitalize on These 3 Hot Biotech Stocks

The biotech industry is well-positioned for growth thanks to rising demand for quality healthcare, the prevalence of chronic diseases, and the government’s push to boost domestic biotech production and...

ACOR : 12.53 (+0.08%)
CORT : 26.66 (-0.26%)
LGND : 61.78 (+0.62%)
XBI : 80.53 (+0.01%)
Are These 3 Biotech Stocks Good Buys?

Given that the biotech sector is rapidly expanding with robust demand, technology advancements, and government initiatives, fundamentally strong biotech stocks Incyte (INCY), Corcept Therapeutics (CORT),...

CORT : 26.66 (-0.26%)
INCY : 54.55 (-1.14%)
TRDA : 13.04 (-2.40%)
Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics...

CORT : 26.66 (-0.26%)
FOLD : 11.35 (-1.05%)
HRMY : 31.40 (+1.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 27.92
2nd Resistance Point 27.51
1st Resistance Point 27.12
Last Price 26.66
1st Support Level 26.32
2nd Support Level 25.91
3rd Support Level 25.52

See More

52-Week High 34.28
Fibonacci 61.8% 28.00
Last Price 26.66
Fibonacci 50% 26.07
Fibonacci 38.2% 24.13
52-Week Low 17.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar